These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 24210418)

  • 21. Bioresorbable vascular scaffolds in left main coronary artery disease.
    Everaert B; Capranzano P; Tamburino C; Seth A; van Geuns RJ
    EuroIntervention; 2015; 11 Suppl V():V135-8. PubMed ID: 25983148
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Follow-up of coronary artery patency after implantation of bioresorbable coronary scaffolds: The emerging role of magnetic coronary artery imaging.
    Zuin M; Rigatelli G; Scaranello F; Rinuncini M; Picariello C; D'Elia K; Fejzo M; Roncon L
    Cardiovasc Revasc Med; 2017; 18(5):369-373. PubMed ID: 28254259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. "Golden tube" with favorable vessel remodeling at four-year follow-up after bioresorbable vascular scaffold implantation for moderate to severe calcified lesions: Insights from intravascular imaging.
    Mitomo S; Candilio L; Tanaka A; Latib A; Colombo A
    Cardiol J; 2018; 25(4):532-533. PubMed ID: 30211931
    [No Abstract]   [Full Text] [Related]  

  • 24. Head-to-head comparison of the neointimal response between metallic and bioresorbable everolimus-eluting scaffolds using optical coherence tomography.
    Gomez-Lara J; Brugaletta S; Farooq V; Onuma Y; Diletti R; Windecker S; Thuesen L; McClean D; Koolen J; Whitbourn R; Dudek D; Smits PC; Chevalier B; Regar E; Veldhof S; Rapoza R; Ormiston JA; Garcia-Garcia HM; Serruys PW
    JACC Cardiovasc Interv; 2011 Dec; 4(12):1271-80. PubMed ID: 22192368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Three-dimensional optical frequency domain imaging in conventional percutaneous coronary intervention: the potential for clinical application.
    Farooq V; Gogas BD; Okamura T; Heo JH; Magro M; Gomez-Lara J; Onuma Y; Radu MD; Brugaletta S; van Bochove G; van Geuns RJ; Garcìa-Garcìa HM; Serruys PW
    Eur Heart J; 2013 Mar; 34(12):875-85. PubMed ID: 22108834
    [No Abstract]   [Full Text] [Related]  

  • 26. Early U.S. Experience Following FDA Approval of the ABBOTT Vascular Bioresorbable Vascular Scaffold: Optimal Deployment Technique Using High Resolution Coronary Artery Imaging.
    Rizik DG; Padaliya BB
    J Interv Cardiol; 2016 Oct; 29(5):546-548. PubMed ID: 27492571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of a bioresorbable novolimus eluting vascular scaffold fails a hybrid PCI strategy with drug eluting stent.
    Schneider VS; Skurk C; Riedel M; Abdelwahed YS; Landmesser U; Leistner DM
    Clin Res Cardiol; 2017 Jul; 106(7):557-559. PubMed ID: 28374059
    [No Abstract]   [Full Text] [Related]  

  • 28. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
    Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Very late metallic stent malapposition and in-stent restenosis treated with a bioresorbable scaffold: a novel alternative for an old problem.
    Foin N; Lee R; Wong P; Low AF
    EuroIntervention; 2015 Aug; 11(4):e1. PubMed ID: 26298237
    [No Abstract]   [Full Text] [Related]  

  • 30. A broken promise: 4-year optical coherence tomography follow-up of a bioresorbable vascular scaffold.
    Versaci F; Vizzari G; Prati F; Biondi-Zoccai G
    J Cardiovasc Med (Hagerstown); 2020 May; 21(5):398-400. PubMed ID: 32243342
    [No Abstract]   [Full Text] [Related]  

  • 31. A review of bioresorbable scaffolds: hype or hope?
    Tan HC; Ananthakrishna R
    Singapore Med J; 2017 Sep; 58(9):512-515. PubMed ID: 27868135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of invasive imaging in acute and long-term assessment of bioresorbable scaffold technology.
    Chamié D; Garcia-Garcia H; Costa RA; Onuma Y; Abizaid A; Serruys PW
    Catheter Cardiovasc Interv; 2016 Nov; 88(S1):38-53. PubMed ID: 27797463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. First-in-human description of everolimus-eluting bioabsorbable vascular scaffold implantation for the treatment of drug-eluting stent failure: insights from optical coherence tomography.
    Grasso C; Attizzani GF; Patané M; Ohno Y; Capodanno D; Tamburino C
    Int J Cardiol; 2013 Oct; 168(4):4490-1. PubMed ID: 23890924
    [No Abstract]   [Full Text] [Related]  

  • 34. Long-term intravascular follow-up of coronary bifurcation treatment with Absorb bioresorbable vascular scaffold.
    Vanhaverbeke M; McCutcheon K; Dubois C; Bennett J
    Acta Cardiol; 2018 Aug; 73(4):413-414. PubMed ID: 29277145
    [No Abstract]   [Full Text] [Related]  

  • 35. Optimisation of percutaneous coronary intervention: indispensables for bioresorbable scaffolds.
    Tenekecioglu E; Bourantas CV; Abdelghani M; Sotomi Y; Suwannasom P; Tateishi H; Onuma Y; Yılmaz M; Serruys PW
    Expert Rev Cardiovasc Ther; 2016 Sep; 14(9):1053-70. PubMed ID: 27376592
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fracture with the newer bioresorbable vascular scaffolds.
    Elwany M; Di Palma G; Cortese B
    Catheter Cardiovasc Interv; 2017 Oct; 90(4):582-583. PubMed ID: 28295999
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sealing of calcified plaques after bioresorbable scaffold implantations: a five-year follow up.
    Tenekecioglu E; Bourantas CV; Onuma Y; Serruys PW
    Int J Cardiovasc Imaging; 2017 Apr; 33(4):451-452. PubMed ID: 28004209
    [No Abstract]   [Full Text] [Related]  

  • 38. Intracoronary optical coherence tomography and histology at 1 month and 2, 3, and 4 years after implantation of everolimus-eluting bioresorbable vascular scaffolds in a porcine coronary artery model: an attempt to decipher the human optical coherence tomography images in the ABSORB trial.
    Onuma Y; Serruys PW; Perkins LE; Okamura T; Gonzalo N; García-García HM; Regar E; Kamberi M; Powers JC; Rapoza R; van Beusekom H; van der Giessen W; Virmani R
    Circulation; 2010 Nov; 122(22):2288-300. PubMed ID: 20975003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bioresorbable metal scaffold for cardiovascular application: current knowledge and future perspectives.
    Kitabata H; Waksman R; Warnack B
    Cardiovasc Revasc Med; 2014 Mar; 15(2):109-16. PubMed ID: 24684760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coronary artery perforation at the level of two-overlapping bioresorbable vascular scaffolds: The importance of vessel sizing and scaffold thickness.
    Pichette M; Chevalier F; Généreux P
    Catheter Cardiovasc Interv; 2015 Oct; 86(4):686-91. PubMed ID: 26122768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.